BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Faustino C, Pinheiro L. Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 2020;12:E29. [PMID: 31906268 DOI: 10.3390/pharmaceutics12010029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Zhang W, Ju JX, Wang LJ, Huang RY, Xu YF, Zhang HL, Qi JL. Gender differences in acute toxicity, toxicokinetic and tissue distribution of amphotericin B liposomes in rats. Toxicol Lett 2021;338:78-84. [PMID: 33309996 DOI: 10.1016/j.toxlet.2020.12.004] [Reference Citation Analysis]
2 Jebastin K, Narayanasamy D. Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers. J Liposome Res 2022;:1-33. [PMID: 35543241 DOI: 10.1080/08982104.2022.2069809] [Reference Citation Analysis]
3 Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics (Basel) 2020;9:E312. [PMID: 32526921 DOI: 10.3390/antibiotics9060312] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 19.5] [Reference Citation Analysis]
4 Magalhães EP, Silva BP, Aires NL, Ribeiro LR, Ali A, Cavalcanti MM, Nunes JVS, Sampaio TL, de Menezes RRPPB, Martins AMC. (-)-α-Bisabolol as a protective agent against epithelial renal cytotoxicity induced by amphotericin B. Life Sci 2021;291:120271. [PMID: 34974077 DOI: 10.1016/j.lfs.2021.120271] [Reference Citation Analysis]
5 Liu Y, Mei Z, Mei L, Tang J, Yuan W, Srinivasan S, Ackermann R, Schwendeman AS. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products. Eur J Pharm Biopharm 2020;157:241-9. [PMID: 32980448 DOI: 10.1016/j.ejpb.2020.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Busch D, Bogdan C, Erfurt-Berge C. Clinical Manifestation of Cutaneous Leishmaniasis Following a Mechanical Trauma. Int J Low Extrem Wounds 2020;:1534734620968964. [PMID: 33135533 DOI: 10.1177/1534734620968964] [Reference Citation Analysis]
7 Kim EM, Jeong HJ. Liposomes: Biomedical Applications. Chonnam Med J 2021;57:27-35. [PMID: 33537216 DOI: 10.4068/cmj.2021.57.1.27] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Suknuntha K, Wattanapoka K, Poonpattanachai P, Titipornwanich N, Sripakdee W. Compatibility and Physical Properties of Dexamethasone-Ondansetron Intravenous Admixture. Hosp Pharm. [DOI: 10.1177/00185787221074563] [Reference Citation Analysis]
9 Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, Wu J, Chen Z, Yin L, He W. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B 2021;11:2585-604. [PMID: 34522599 DOI: 10.1016/j.apsb.2021.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Savarirajan D, Ramesh VM, Muthaiyan A. In vitro antidermatophytic activity of bioactive compounds from selected medicinal plants. J Anal Sci Technol 2021;12:53. [PMID: 34745684 DOI: 10.1186/s40543-021-00304-3] [Reference Citation Analysis]
11 Kapoor B, Kochhar RS, Gulati M, Rani P, Gupta R, Kumar Singh S, Machawal L, Thakur A. Triumvirate to treat mucormycosis: Interplay of pH, metal ions and antifungal drugs. Medical Hypotheses 2022;159:110748. [DOI: 10.1016/j.mehy.2021.110748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lin B, Ma Y, Wang J. Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives. Front Bioeng Biotechnol 2022;10:870049. [DOI: 10.3389/fbioe.2022.870049] [Reference Citation Analysis]
13 Herrada J, Gamal A, Long L, Sanchez SP, McCormick TS, Ghannoum MA. In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris. Antimicrob Agents Chemother 2021;65:e00306-21. [PMID: 33846131 DOI: 10.1128/AAC.00306-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Alghuthaymi MA, Hassan AA, Kalia A, Sayed El Ahl RMH, El Hamaky AAM, Oleksak P, Kuca K, Abd-Elsalam KA. Antifungal Nano-Therapy in Veterinary Medicine: Current Status and Future Prospects. J Fungi (Basel) 2021;7:494. [PMID: 34206304 DOI: 10.3390/jof7070494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Aigner M, Lass-Flörl C. Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached? J Fungi (Basel) 2020;6:E66. [PMID: 32443486 DOI: 10.3390/jof6020066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
16 Sahu RK, Salem-Bekhit MM, Bhattacharjee B, Almoshari Y, Ikbal AMA, Alshamrani M, Bharali A, Salawi A, Widyowati R, Alshammari A, Elbagory I. Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies. Antibiotics (Basel) 2021;10:1079. [PMID: 34572661 DOI: 10.3390/antibiotics10091079] [Reference Citation Analysis]
17 Vitorino LS, Dos Santos TC, Bessa IAA, Santos ECS, Verçoza BRF, de Oliveira LAS, Rodrigues JCF, Ronconi CM. Amphotericin-B-loaded polymer-functionalized reduced graphene oxides for Leishmania amazonensis chemo-photothermal therapy. Colloids Surf B Biointerfaces 2021;209:112169. [PMID: 34752985 DOI: 10.1016/j.colsurfb.2021.112169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ortega-Blake I, Fernández-Zertuche M, Regla I, Sánchez-Peña W, Gómez-Solis A, Jaimes-Chavez P, Galván-Hernández A, Tovar-Garduño E, Rodríguez-Fragoso L. Preclinical safety evaluation of amphotericin A21: A novel antifungal. Basic Clin Pharmacol Toxicol 2021;129:72-81. [PMID: 33900024 DOI: 10.1111/bcpt.13592] [Reference Citation Analysis]
19 McGraw E, Dissanayaka RH, Vaughan JC, Kunte N, Mills G, Laurent GM, Avila LA. Laser-Assisted Delivery of Molecules in Fungal Cells. ACS Appl Bio Mater 2020;3:6167-76. [PMID: 35021749 DOI: 10.1021/acsabm.0c00720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Banshoya K, Kaneo Y, Tanaka T, Yamamoto S, Maeda H. Development of an amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity. Int J Pharm 2020;589:119813. [PMID: 32871218 DOI: 10.1016/j.ijpharm.2020.119813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano 2021. [PMID: 34181394 DOI: 10.1021/acsnano.1c04996] [Cited by in Crossref: 86] [Cited by in F6Publishing: 61] [Article Influence: 86.0] [Reference Citation Analysis]
22 Lipa-Castro A, Nicolas V, Angelova A, Mekhloufi G, Prost B, Chéron M, Faivre V, Barratt G. Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid. Int J Pharm 2021;603:120688. [PMID: 33965540 DOI: 10.1016/j.ijpharm.2021.120688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Sousa HR, de Frazão S, de Oliveira Júnior GP, Albuquerque P, Nicola AM. Cryptococcal Virulence in Humans: Learning From Translational Studies With Clinical Isolates. Front Cell Infect Microbiol 2021;11:657502. [PMID: 33968804 DOI: 10.3389/fcimb.2021.657502] [Reference Citation Analysis]
24 El-ganiny AM, Kamel HA, Yossef NE, Mansour B, El-baz AM. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Debnath SK, Srivastava R, Debnath M, Omri A. Status of inhalable antimicrobial agents for lung infection: progress and prospects. Expert Rev Respir Med 2021;:1-20. [PMID: 33866900 DOI: 10.1080/17476348.2021.1919514] [Reference Citation Analysis]
26 Khan SY, Ahmad I. Clinical Efficacy of a Novel Lipid-based Thymoquinone Gel: A Two-arm, Single-blinded, and Randomized Study. J Int Soc Prev Community Dent 2021;11:376-81. [PMID: 34430497 DOI: 10.4103/jispcd.JISPCD_49_21] [Reference Citation Analysis]
27 Kaur K, Kumar P, Kush P. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Biomed Pharmacother 2020;128:110297. [PMID: 32480227 DOI: 10.1016/j.biopha.2020.110297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Dubashynskaya NV, Skorik YA. Polymyxin Delivery Systems: Recent Advances and Challenges. Pharmaceuticals (Basel) 2020;13:E83. [PMID: 32365637 DOI: 10.3390/ph13050083] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Johnson MD. Antifungals in Clinical Use and the Pipeline. Infect Dis Clin North Am 2021;35:341-71. [PMID: 34016281 DOI: 10.1016/j.idc.2021.03.005] [Reference Citation Analysis]
30 Jamaledin R, Yiu CKY, Zare EN, Niu LN, Vecchione R, Chen G, Gu Z, Tay FR, Makvandi P. Advances in Antimicrobial Microneedle Patches for Combating Infections. Adv Mater 2020;32:e2002129. [PMID: 32602146 DOI: 10.1002/adma.202002129] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 49.5] [Reference Citation Analysis]
31 Thakur AK, Kumar R, Vipin Kumar V, Kumar A, Kumar Gaurav G, Naresh Gupta K. A critical review on thermodynamic and hydrodynamic modeling and simulation of liquid antisolvent crystallization of pharmaceutical compounds. Journal of Molecular Liquids 2022;362:119663. [DOI: 10.1016/j.molliq.2022.119663] [Reference Citation Analysis]
32 Santoso P, Minamihata K, Ishimine Y, Taniguchi H, Komada T, Sato R, Goto M, Takashima T, Taira T, Kamiya N. Enhancement of the Antifungal Activity of Chitinase by Palmitoylation and the Synergy of Palmitoylated Chitinase with Amphotericin B. ACS Infect Dis 2022;8:1051-61. [PMID: 35471825 DOI: 10.1021/acsinfecdis.2c00052] [Reference Citation Analysis]
33 Olías-Molero AI, de la Fuente C, Cuquerella M, Torrado JJ, Alunda JM. Antileishmanial Drug Discovery and Development: Time to Reset the Model? Microorganisms 2021;9:2500. [PMID: 34946102 DOI: 10.3390/microorganisms9122500] [Reference Citation Analysis]
34 Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics 2022;11:718. [DOI: 10.3390/antibiotics11060718] [Reference Citation Analysis]
35 Jafari M, Abolmaali SS, Tamaddon AM, Zomorodian K, Sarkari BS. Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine (Lond) 2021;16:857-77. [PMID: 33890492 DOI: 10.2217/nnm-2020-0482] [Reference Citation Analysis]
36 Hauser PV, Chang H, Yanagawa N, Hamon M. Nanotechnology, Nanomedicine, and the Kidney. Applied Sciences 2021;11:7187. [DOI: 10.3390/app11167187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
37 Rajablou K, Attar H, Sadjady SK, Heydarinasab A. THE IN-VITRO STUDY OF NOVEL PHOSPHOLIPID MICELLES LOADED WITH AMPHOTERICIN B ON PLASMODIUM FALCIPARUM PROTOZOAN. Chem Phys Lipids 2022;:105180. [PMID: 35247432 DOI: 10.1016/j.chemphyslip.2022.105180] [Reference Citation Analysis]
38 Kontogiannidou E, Meikopoulos T, Gika H, Panteris E, Vizirianakis IS, Müllertz A, Fatouros DG. In Vitro Evaluation of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) Containing Room Temperature Ionic Liquids (RTILs) for the Oral Delivery of Amphotericin B. Pharmaceutics 2020;12:E699. [PMID: 32722400 DOI: 10.3390/pharmaceutics12080699] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
39 León-Buitimea A, Garza-Cervantes JA, Gallegos-Alvarado DY, Osorio-Concepción M, Morones-Ramírez JR. Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis. Pathogens 2021;10:1303. [PMID: 34684252 DOI: 10.3390/pathogens10101303] [Reference Citation Analysis]
40 Nimtrakul P, Williams DB, Tiyaboonchai W, Prestidge CA. Copolymeric Micelles Overcome the Oral Delivery Challenges of Amphotericin B. Pharmaceuticals (Basel) 2020;13:E121. [PMID: 32545189 DOI: 10.3390/ph13060121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Nami S, Aghebati-Maleki A, Aghebati-Maleki L. Current applications and prospects of nanoparticles for antifungal drug delivery. EXCLI J 2021;20:562-84. [PMID: 33883983 DOI: 10.17179/excli2020-3068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Abdallah MH, Elsewedy HS, AbuLila AS, Almansour K, Unissa R, Elghamry HA, Soliman MS. Quality by Design for Optimizing a Novel Liposomal Jojoba Oil-Based Emulgel to Ameliorate the Anti-Inflammatory Effect of Brucine. Gels 2021;7:219. [PMID: 34842709 DOI: 10.3390/gels7040219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Weldrick PJ, Hardman MJ, Paunov VN. Superenhanced Removal of Fungal Biofilms by Protease‐Functionalized Amphotericin B Nanocarriers. Adv NanoBio Res 2021;1:2000027. [DOI: 10.1002/anbr.202000027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
44 Di Mambro T, Vanzolini T, Bruscolini P, Perez-Gaviro S, Marra E, Roscilli G, Bianchi M, Fraternale A, Schiavano GF, Canonico B, Magnani M. A new humanized antibody is effective against pathogenic fungi in vitro. Sci Rep 2021;11:19500. [PMID: 34593880 DOI: 10.1038/s41598-021-98659-5] [Reference Citation Analysis]